Type I collagen can function as a reservoir of basic fibroblast growth factor.

[1]  J. Isner,et al.  Mouse model of angiogenesis. , 1998, The American journal of pathology.

[2]  K. Piez,et al.  Characterization of the product formed by renaturation of alpha 1-CB2, a small peptide from collagen. , 1970, Biochemistry.

[3]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.

[4]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[5]  Y. Tabata,et al.  Gelatin Sheet Incorporating Basic Fibroblast Growth Factor Enhances Healing of Devascularized Sternum in Diabetic Rats , 2001, Circulation.

[6]  K. Nakao,et al.  Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Y. Kihara,et al.  Activation of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Induces Apoptosis in Cultured Neonatal Rat Cardiac Myocytes , 2001, Circulation.

[8]  Y. Tabata,et al.  Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits. , 2002, Biomaterials.

[9]  J. Quigley,et al.  Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.

[10]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Yasuhiko Tabata,et al.  Collagenous matrices as release carriers of exogenous growth factors. , 2004, Biomaterials.

[12]  Y. Ikada,et al.  Biodegradation of hydrogel carrier incorporating fibroblast growth factor. , 1999, Tissue engineering.

[13]  K. Ouriel.  Peripheral arterial disease , 2001, The Lancet.

[14]  M. Klagsbrun,et al.  Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesis , 1991, Journal of cellular biochemistry.

[15]  Y. Luo,et al.  Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. , 2001, Biochemistry.

[16]  R. Powers,et al.  Erratum: Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor (Biochemistry (April 22, 1997) 36:16 (4782-4791)) , 1997 .

[17]  D. Rifkin,et al.  Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan , 1989, Journal of cellular physiology.

[18]  Y. Tabata,et al.  Controlled Release of Hepatocyte Growth Factor from Gelatin Hydrogels Based on Hydrogel Degradation , 2001, Journal of drug targeting.

[19]  Antonios G. Mikos,et al.  Growth Factor Delivery for Tissue Engineering , 2000, Pharmaceutical Research.

[20]  Y. Ikada,et al.  In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. , 1998, Biomaterials.

[21]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[22]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[23]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[24]  E. Schönherr,et al.  Extracellular Matrix and Cytokines: A Functional Unit , 2000, Developmental immunology.

[25]  J. Heino,et al.  Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth. , 1992, The Journal of biological chemistry.

[26]  Y. Kato,et al.  Local Application of Basic Fibroblast Growth Factor Minipellet Induces the Healing of Segmental Bony Defects in Rabbits , 1998, Calcified Tissue International.

[27]  T. Nakamura,et al.  Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. , 1994, The Journal of biological chemistry.

[28]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[29]  M. Capogrossi,et al.  Platelet-derived Growth Factor-BB and Basic Fibroblast Growth Factor Directly Interact in Vitro with High Affinity* , 2002, The Journal of Biological Chemistry.

[30]  D. Hicklin,et al.  Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. , 1994, The Journal of biological chemistry.

[31]  R. Langer,et al.  Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  V. Sasisekharan,et al.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Powers,et al.  Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. , 1997, Biochemistry.

[34]  R. Gamelli,et al.  Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. , 1996, Surgery.

[35]  G. M. Fox,et al.  Binding of heparin to basic fibroblast growth factor induces a conformational change. , 1992, Archives of biochemistry and biophysics.

[36]  Y. Courtois,et al.  Specific binding of basic fibroblast growth factor to basement membrane‐like structures and to purified heparan sulfate proteoglycan of the EHS tumor , 1988, Journal of cellular physiology.

[37]  J. Veerkamp,et al.  Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. , 2002, Journal of biomedical materials research.

[38]  Y. Tabata,et al.  Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. , 2003, The Journal of urology.